Amicus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Amicus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Amicus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Amicus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Amicus Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Amicus Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Michael G. Raab
Chairman Executive BoardMr. Michael G. Raab has been the Chairman of the company since March 2024. Prior to this, he served as the Independent Director of the company. Mr. Raab also served as the President and Chief Executive Officer of Ardelyx Inc. Previously, he served as the Senior Vice President, Therapeutics and General Manager, Renagel at Genzyme Corporation from 1999 to 2002. Currently, he also serves as a Member of the Board of Directors of Ardelyx Inc and Tempest Therapeutics Inc.
Bradley L. Campbell
Chief Executive Officer; President; Director Executive BoardMr. Bradley L. Campbell has been the President, Director, and Chief Executive Officer of the company since 2022. Previously, he served as President and Chief Operating Officer of the company from 2015 to 2022. Prior to this, he served as the Product Manager for Myozyme at Genzyme. Previously, he served as the Strategy Consultant of Marakon Associates. Mr. Campbell also served in Sales and Marketing for Bristol-Myers Squibb. Earlier, he served as Director of Gennao Bio and ARYA Sciences Acquisition Corp III. Prior to this, he served as the Chief Executive Officer of Amicus.
Simon Harford
Chief Financial Officer Senior ManagementMr. Simon Harford has been the Chief Financial Officer of the company since August 2023. Prior to this, he served as the Chief Financial Officer of Boston-based biotech Albireo Pharma Inc from October 2018 to March 2023. Earlier, he served as Chief Financial Officer at PAREXEL International Corporation. Previously, he served leadership roles at GlaxoSmithKline plc and Eli Lilly and Company. Earlier, he spent 20 years at Eli Lilly and Company in numerous senior leadership roles in the U.S. and Europe including Head of Investor Relations, European Chief Finance Officer and Corporate Controller.
Ellen S. Rosenberg
Chief Legal Officer Senior ManagementMs. Ellen S. Rosenberg has been the Chief Legal Officer of the company since 2019. Prior to this, she served as the Corporate Secretary and General Counsel. Ms. Rosenberg also served as the Senior Vice President and Associate General Counsel of Shire. Previously, she served as the Associate General Counsel for the Metabolic Endocrinology division at EMD Serono Inc, an affiliate of Merck KGaA.
David M. Clark
Chief People Officer Senior ManagementMr. David M. Clark has been the Chief People Officer of the company since 2018. Prior to this, he served as the Vice President of Global Human Resources at Alibaba Group from 2016 to 2018. Mr. Clark also served as the Chief Learning Officer and Senior Vice President of Human Resources at American Express.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer